Dror Yosef Abramov
CIK: 0002034083
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SLXN
Silexion Therapeutics Corp
Director
Discretionary Trading P&L
Holdings
About Abramov Dror Yosef
Abramov Dror Yosef (SEC CIK 0002034083) files insider reports with the SEC as Director of Silexion Therapeutics Corp (SLXN).
Signal8 holds 2 ownership filings by Abramov Dror Yosef, all Form 4s, filed between Dec 31, 2025 and Feb 23, 2026. Those filings report 2 transactions, from Feb 9, 2025 to Feb 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Abramov Dror Yosef's filings is in HERZLIYA, L3.
Recent filings by Abramov Dror Yosef
Other insiders filing for Silexion Therapeutics Corp (SLXN)
- Shirvan Mitchell, CSO and CDO
- Horenshtein Hadar Mirit, CFO and Secretary
- Hadar Ilan, Chairman and CEO
- Noy Shlomo, Director
- Alon Ruth, Director
- Peled Amnon, Director